Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Palus
D Hoyer

Showing results (11-20 of 400) with videos related to

Pageof 40
Sort By:
Clinical Chemistry|March 1, 2015
CommentaryJames D Hoyer
Mayo Clinic Proceedings|October 1, 1993
Leukocyte differentialJ D Hoyer
European Journal of Pharmacology|February 16, 1988
5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigraD Hoyer, P Schoeffter
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 22, 1999
Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activityS Siehler, D Hoyer
Neuroscience|January 1, 1995
Co-expression of somatostatin SSTR-3 and SSTR-4 receptor messenger RNAs in the rat brainJ Pérez, D Hoyer
Journal of Cardiovascular Pharmacology|January 1, 1982
[125Iodo]BE 2254, a new radioligand for alpha 1-adrenoceptorsG Engel, D Hoyer
Journal of Receptor Research|January 1, 1991
5-HT receptors: subtypes and second messengersD Hoyer, P Schoeffter
Neuropharmacology|April 1, 1997
5-HT receptor classification and nomenclature: towards a harmonization with the human genomeD Hoyer, G Martin
The European Journal of Neuroscience|December 3, 1999
Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesisA Vezzani, D Hoyer
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1989
5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonistsP Schoeffter, D Hoyer
Pageof 40

Showing results (11-20 of 400) with videos related to

Sort By:
Pageof 40
Clinical Chemistry|March 1, 2015
CommentaryJames D Hoyer
Mayo Clinic Proceedings|October 1, 1993
Leukocyte differentialJ D Hoyer
European Journal of Pharmacology|February 16, 1988
5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigraD Hoyer, P Schoeffter
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 22, 1999
Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activityS Siehler, D Hoyer
Neuroscience|January 1, 1995
Co-expression of somatostatin SSTR-3 and SSTR-4 receptor messenger RNAs in the rat brainJ Pérez, D Hoyer
Journal of Cardiovascular Pharmacology|January 1, 1982
[125Iodo]BE 2254, a new radioligand for alpha 1-adrenoceptorsG Engel, D Hoyer
Journal of Receptor Research|January 1, 1991
5-HT receptors: subtypes and second messengersD Hoyer, P Schoeffter
Neuropharmacology|April 1, 1997
5-HT receptor classification and nomenclature: towards a harmonization with the human genomeD Hoyer, G Martin
The European Journal of Neuroscience|December 3, 1999
Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesisA Vezzani, D Hoyer
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1989
5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonistsP Schoeffter, D Hoyer
Pageof 40